{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T20:43:35Z","timestamp":1793133815092,"version":"4.5.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82302251"],"award-info":[{"award-number":["82302251"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U24A20758"],"award-info":[{"award-number":["U24A20758"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82472094"],"award-info":[{"award-number":["82472094"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National High Level Hospital Clinical Research Funding","award":["2022-PUMCH-C-037"],"award-info":[{"award-number":["2022-PUMCH-C-037"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s00259-026-07970-8","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:32:15Z","timestamp":1780471935000},"page":"6050-6062","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["FAPI PET\/CT in post-PCI coronary disease: in-stent restenosis characterization, MACE association, and limited short-term modulation by lipid-lowering therapy: FAPI athero trial"],"prefix":"10.1007","volume":"53","author":[{"given":"Ximin","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiqiong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiqi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhai","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixin","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhichao","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Hacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1216-083X","authenticated-orcid":false,"given":"Li","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,3]]},"reference":[{"key":"7970_CR1","doi-asserted-by":"publisher","first-page":"C13","DOI":"10.1016\/j.jacc.2005.10.065","volume":"47","author":"R Virmani","year":"2006","unstructured":"Virmani R, Burke AP, Farb A, Kolodgie FD. Pathology of the vulnerable plaque. J Am Coll Cardiol. 2006;47:C13\u20138. https:\/\/doi.org\/10.1016\/j.jacc.2005.10.065.","journal-title":"J Am Coll Cardiol"},{"key":"7970_CR2","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.jacc.2022.05.017","volume":"80","author":"G Giustino","year":"2022","unstructured":"Giustino G, Colombo A, Camaj A, Yasumura K, Mehran R, Stone GW, et al. Coronary In-Stent Restenosis: JACC State-of-the-Art Review. J Am Coll Cardiol. 2022;80:348\u201372. https:\/\/doi.org\/10.1016\/j.jacc.2022.05.017.","journal-title":"J Am Coll Cardiol"},{"key":"7970_CR3","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/s0735-1097(01)01742-9","volume":"39","author":"HC Lowe","year":"2002","unstructured":"Lowe HC, Oesterle SN, Khachigian LM. Coronary in-stent restenosis: current status and future strategies. J Am Coll Cardiol. 2002;39:183\u201393. https:\/\/doi.org\/10.1016\/s0735-1097(01)01742-9.","journal-title":"J Am Coll Cardiol"},{"key":"7970_CR4","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1093\/eurheartj\/ehq519","volume":"32","author":"CE Brokopp","year":"2011","unstructured":"Brokopp CE, Schoenauer R, Richards P, Bauer S, Lohmann C, Emmert MY, et al. Fibroblast activation protein is induced by inflammation and degrades type I collagen in thin-cap fibroatheromata. Eur Heart J. 2011;32:2713\u201322. https:\/\/doi.org\/10.1093\/eurheartj\/ehq519.","journal-title":"Eur Heart J"},{"key":"7970_CR5","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.jacc.2024.10.103","volume":"85","author":"AK Barton","year":"2025","unstructured":"Barton AK, Craig NJ, Loganath K, Joshi S, Tsampasian V, Mahendran M, et al. Myocardial Fibroblast Activation After Acute Myocardial Infarction: A Positron Emission Tomography and Magnetic Resonance Study. J Am Coll Cardiol. 2025;85:578\u201391. https:\/\/doi.org\/10.1016\/j.jacc.2024.10.103.","journal-title":"J Am Coll Cardiol"},{"key":"7970_CR6","doi-asserted-by":"publisher","first-page":"948","DOI":"10.2967\/jnumed.121.262863","volume":"63","author":"M Wu","year":"2022","unstructured":"Wu M, Ning J, Li J, Lai Z, Shi X, Xing H, et al. Feasibility of In Vivo Imaging of Fibroblast Activation Protein in Human Arterial Walls. J Nucl Med. 2022;63:948\u201351. https:\/\/doi.org\/10.2967\/jnumed.121.262863.","journal-title":"J Nucl Med"},{"key":"7970_CR7","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.jacc.2021.04.102","volume":"78","author":"GG Schwartz","year":"2021","unstructured":"Schwartz GG, Szarek M, Bittner VA, Diaz R, Goodman SG, Jukema JW, et al. Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol. J Am Coll Cardiol. 2021;78:421\u201333. https:\/\/doi.org\/10.1016\/j.jacc.2021.04.102.","journal-title":"J Am Coll Cardiol"},{"key":"7970_CR8","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1016\/j.jacc.2023.02.018","volume":"81","author":"CM Ballantyne","year":"2023","unstructured":"Ballantyne CM, Banka P, Mendez G, Garcia R, Rosenstock J, Rodgers A, et al. Phase 2b Randomized Trial of the Oral PCSK9 Inhibitor MK-0616. J Am Coll Cardiol. 2023;81:1553\u201364. https:\/\/doi.org\/10.1016\/j.jacc.2023.02.018.","journal-title":"J Am Coll Cardiol"},{"key":"7970_CR9","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1161\/circulationaha.122.063399","volume":"147","author":"P Gaba","year":"2023","unstructured":"Gaba P, O\u2019Donoghue ML, Park JG, Wiviott SD, Atar D, Kuder JF, et al. Association Between Achieved Low-Density Lipoprotein Cholesterol Levels and Long-Term Cardiovascular and Safety Outcomes: An Analysis of FOURIER-OLE. Circulation. 2023;147:1192\u2013203. https:\/\/doi.org\/10.1161\/circulationaha.122.063399.","journal-title":"Circulation"},{"key":"7970_CR10","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1161\/circulationaha.122.063460","volume":"149","author":"F Raal","year":"2024","unstructured":"Raal F, Durst R, Bi R, Talloczy Z, Maheux P, Lesogor A, et al. Efficacy, Safety, and Tolerability of Inclisiran in Patients With Homozygous Familial Hypercholesterolemia: Results From the ORION-5 Randomized Clinical Trial. Circulation. 2024;149:354\u201362. https:\/\/doi.org\/10.1161\/circulationaha.122.063460.","journal-title":"Circulation"},{"key":"7970_CR11","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1001\/jama.2022.5218","volume":"327","author":"L R\u00e4ber","year":"2022","unstructured":"R\u00e4ber L, Ueki Y, Otsuka T, Losdat S, H\u00e4ner JD, Lonborg J, et al. Effect of Alirocumab Added to High-Intensity Statin Therapy on Coronary Atherosclerosis in Patients With Acute Myocardial Infarction: The PACMAN-AMI Randomized Clinical Trial. JAMA. 2022;327:1771\u201381. https:\/\/doi.org\/10.1001\/jama.2022.5218.","journal-title":"JAMA"},{"key":"7970_CR12","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1056\/NEJMoa1912387","volume":"382","author":"KK Ray","year":"2020","unstructured":"Ray KK, Wright RS, Kallend D, Koenig W, Leiter LA, Raal FJ, et al. Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol. N Engl J Med. 2020;382:1507\u201319. https:\/\/doi.org\/10.1056\/NEJMoa1912387.","journal-title":"N Engl J Med"},{"key":"7970_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jacc.2013.09.019","volume":"63","author":"AS Jaipersad","year":"2014","unstructured":"Jaipersad AS, Lip GY, Silverman S, Shantsila E. The role of monocytes in angiogenesis and atherosclerosis. J Am Coll Cardiol. 2014;63:1\u201311. https:\/\/doi.org\/10.1016\/j.jacc.2013.09.019.","journal-title":"J Am Coll Cardiol"},{"key":"7970_CR14","doi-asserted-by":"publisher","first-page":"3011","DOI":"10.1007\/s00259-023-06245-w","volume":"50","author":"A Kosmala","year":"2023","unstructured":"Kosmala A, Serfling SE, Michalski K, Lindner T, Schirbel A, Higuchi T, et al. Molecular imaging of arterial fibroblast activation protein: association with calcified plaque burden and cardiovascular risk factors. Eur J Nucl Med Mol Imaging. 2023;50:3011\u201321. https:\/\/doi.org\/10.1007\/s00259-023-06245-w.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7970_CR15","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1161\/atvbaha.108.179739","volume":"30","author":"AV Finn","year":"2010","unstructured":"Finn AV, Nakano M, Narula J, Kolodgie FD, Virmani R. Concept of vulnerable\/unstable plaque. Arterioscler Thromb Vasc Biol. 2010;30:1282\u201392. https:\/\/doi.org\/10.1161\/atvbaha.108.179739.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"7970_CR16","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1161\/circulationaha.119.044914","volume":"141","author":"TC Kuhn","year":"2020","unstructured":"Kuhn TC, Knobel J, Burkert-Rettenmaier S, Li X, Meyer IS, Jungmann A, et al. Secretome Analysis of Cardiomyocytes Identifies PCSK6 (Proprotein Convertase Subtilisin\/Kexin Type 6) as a Novel Player in Cardiac Remodeling After Myocardial Infarction. Circulation. 2020;141:1628\u201344. https:\/\/doi.org\/10.1161\/circulationaha.119.044914.","journal-title":"Circulation"},{"key":"7970_CR17","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/j.jacc.2015.01.039","volume":"65","author":"G Giustino","year":"2015","unstructured":"Giustino G, Baber U, Sartori S, Mehran R, Mastoris I, Kini AS, et al. Duration of dual antiplatelet therapy after drug-eluting stent implantation: a systematic review and meta-analysis of randomized controlled trials. J Am Coll Cardiol. 2015;65:1298\u2013310. https:\/\/doi.org\/10.1016\/j.jacc.2015.01.039.","journal-title":"J Am Coll Cardiol"},{"key":"7970_CR18","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1016\/s0140-6736(16)31922-5","volume":"388","author":"ZA Ali","year":"2016","unstructured":"Ali ZA, Maehara A, G\u00e9n\u00e9reux P, Shlofmitz RA, Fabbiocchi F, Nazif TM, et al. Optical coherence tomography compared with intravascular ultrasound and with angiography to guide coronary stent implantation (ILUMIEN III: OPTIMIZE PCI): a randomised controlled trial. Lancet. 2016;388:2618\u201328. https:\/\/doi.org\/10.1016\/s0140-6736(16)31922-5.","journal-title":"Lancet"},{"key":"7970_CR19","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.jcin.2023.10.032","volume":"17","author":"S Biscaglia","year":"2024","unstructured":"Biscaglia S, Verardi FM, Erriquez A, Colaiori I, Cocco M, Cantone A, et al. Coronary Physiology Guidance vs Conventional Angiography for Optimization of Percutaneous Coronary Intervention: The AQVA-II Trial. JACC Cardiovasc Interv. 2024;17:277\u201387. https:\/\/doi.org\/10.1016\/j.jcin.2023.10.032.","journal-title":"JACC Cardiovasc Interv"},{"key":"7970_CR20","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1007\/s00259-024-06986-2","volume":"52","author":"K Zhong","year":"2025","unstructured":"Zhong K, Chen H, Hou P, Cheng L, Guo W, Li Y, et al. Comparison of [(18)F]FAPI-42 and [(18)F]FDG PET\/CT in the evaluation of systemic vasculitis. Eur J Nucl Med Mol Imaging. 2025;52:1083\u201394. https:\/\/doi.org\/10.1007\/s00259-024-06986-2.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7970_CR21","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1007\/s00259-017-3747-8","volume":"44","author":"N Taglieri","year":"2017","unstructured":"Taglieri N, Nanni C, Ghetti G, Bonfiglioli R, Saia F, Bacchi Reggiani ML, et al. Relation between thoracic aortic inflammation and features of plaque vulnerability in the coronary tree in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention. An FDG-positron emission tomography and optical coherence tomography study. Eur J Nucl Med Mol Imaging. 2017;44:1878\u201387. https:\/\/doi.org\/10.1007\/s00259-017-3747-8.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7970_CR22","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1161\/atvbaha.121.317451","volume":"42","author":"A Chattopadhyay","year":"2022","unstructured":"Chattopadhyay A, Guan P, Majumder S, Kaw K, Zhou Z, Zhang C, et al. Preventing Cholesterol-Induced Perk (Protein Kinase RNA-Like Endoplasmic Reticulum Kinase) Signaling in Smooth Muscle Cells Blocks Atherosclerotic Plaque Formation. Arterioscler Thromb Vasc Biol. 2022;42:1005\u201322. https:\/\/doi.org\/10.1161\/atvbaha.121.317451.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"7970_CR23","doi-asserted-by":"publisher","first-page":"102102","DOI":"10.1016\/j.jaccas.2023.102102","volume":"28","author":"A Takasaki","year":"2023","unstructured":"Takasaki A, Kurita T, Hirota Y, Uno K, Kirii Y, Ichikawa M, et al. Isolated Coronary Arteritis Treated With FDG-PET\/CT-Guided Immunosuppressant to Break the Vicious Cycle of In-Stent Restenosis. JACC Case Rep. 2023;28:102102. https:\/\/doi.org\/10.1016\/j.jaccas.2023.102102.","journal-title":"JACC Case Rep"},{"key":"7970_CR24","doi-asserted-by":"publisher","first-page":"e030243","DOI":"10.1161\/jaha.123.030243","volume":"12","author":"MF Buono","year":"2023","unstructured":"Buono MF, Benavente ED, Slenders L, Methorst D, Tessels D, Mili E, et al. Human Plaque Myofibroblasts to Study Mechanisms of Atherosclerosis. J Am Heart Assoc. 2023;12:e030243. https:\/\/doi.org\/10.1161\/jaha.123.030243.","journal-title":"J Am Heart Assoc"},{"key":"7970_CR25","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1093\/cvr\/cvab161","volume":"118","author":"MS Chen","year":"2022","unstructured":"Chen MS, Lee RT, Garbern JC. Senescence mechanisms and targets in the heart. Cardiovasc Res. 2022;118:1173\u201387. https:\/\/doi.org\/10.1093\/cvr\/cvab161.","journal-title":"Cardiovasc Res"},{"key":"7970_CR26","doi-asserted-by":"publisher","first-page":"11853","DOI":"10.1038\/ncomms11853","volume":"7","author":"SM Evrard","year":"2016","unstructured":"Evrard SM, Lecce L, Michelis KC, Nomura-Kitabayashi A, Pandey G, Purushothaman KR, et al. Endothelial to mesenchymal transition is common in atherosclerotic lesions and is associated with plaque instability. Nat Commun. 2016;7:11853. https:\/\/doi.org\/10.1038\/ncomms11853.","journal-title":"Nat Commun"},{"key":"7970_CR27","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1016\/j.jcmg.2022.06.004","volume":"15","author":"X Wang","year":"2022","unstructured":"Wang X, Guo Y, Gao Y, Ren C, Huang Z, Liu B, et al. Feasibility of (68)Ga-Labeled Fibroblast Activation Protein Inhibitor PET\/CT in Light-Chain Cardiac Amyloidosis. JACC Cardiovasc Imaging. 2022;15:1960\u201370. https:\/\/doi.org\/10.1016\/j.jcmg.2022.06.004.","journal-title":"JACC Cardiovasc Imaging"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-026-07970-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-026-07970-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-026-07970-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:05:23Z","timestamp":1785521123000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-026-07970-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,3]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["7970"],"URL":"https:\/\/doi.org\/10.1007\/s00259-026-07970-8","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,3]]},"assertion":[{"value":"14 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This prospective study was approved by the Peking Union Medical College Hospital ethics committee (IRB protocol# I-23PJ266).","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants provided written informed consent.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"M.H. and L.X are editors of EJNMMI.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}